Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacodynamic Studies of a Histone Deacetylase Inhibitor in Friedreich's Ataxia

NCT01589809 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01589809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01589809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacodynamic Studies of a Histone Deacetylase Inhibitor in Friedreich's Ataxia
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2012
Completion date
December 31, 2017
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neurodegenerative disorders